Posted in | News

SN Launches Public Offer for Acquisition of Portugese Cement Manufacturer, Cimpor

Pursuant to the applicable legislation, Companhia Siderurgica Nacional ("CSN") (NYSE: SID) published on this date a preliminary announcement of the launch of a public offer for the acquisition, by CSN itself or indirectly through one or more of its subsidiaries, of 100% of the 672,000,000 shares representing the capital stock of Cimpor - Cimentos de Portugal, SGPS, S.A., whose shares are traded on the Euronext Lisboa under the ticker CPR PL, for euro 5.75 per common share.

The acquisition of Cimpor will contribute to the formation of one the world's largest cement producers, with an annual production capacity of 36 million tonnes of cement.

Cimpor is a Portuguese company with presence in 13 countries in 4 continents (Europe, Asia, South America and Africa). It is the national leader in Portugal, Cabo Verde and Mozambique and occupies important positions in Brazil, Egypt, China, Spain, Turkey, South Africa, Tunisia, Morocco, India and Peru. Its operations in emerging markets, with substantial growth potential, currently account for around 60% of its revenues.

Cimpor is within the top 10 world largest cement manufacturer in terms of market cap. In Brazil, it is ranked 3rd in terms of sales and 4th in production capacity, and it has consistently recorded one of the highest EBITDA margins in the sector.

In 2008, Cimpor recorded revenue of euro 2.1 billion, net income of euro 219 million and EBITDA of euro 586 million. Its net debt on September 30, 2009 totaled euro 1.8 billion.

Source: http://www.csn.com.br/portal/page?_pageid=456,170749&_dad=portal&_schema=PORTAL

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.